Cases of whooping cough, or pertussis, have significantly increased in England, with reports indicating that 2,793 instances occurred between January and March 2024. This marks a dramatic rise from the 858 cases recorded throughout 2023. The UK Health Security Agency (UKHSA) has noted that such spikes are typical every three to five years; however, the recent surge is also thought to be influenced by reduced social interactions and lowered immunity levels due to the COVID-19 pandemic.

Whooping cough primarily affects the lungs and airways, leading to severe coughing fits that can last up to 100 days. The infection poses the highest risk to infants, with five fatalities recently reported among this group.

Health authorities have emphasized the importance of vaccination as a key preventive measure. The UKHSA particularly recommends that pregnant women receive the whooping cough vaccine to confer immunity to their newborns, and that parents adhere strictly to the vaccination schedule for their children. This advice comes amid concerns over declining vaccination rates in recent years.

Public experiences shared with the media highlight the severe impact of whooping cough on individuals. Several people recounted their difficulties with diagnosis and timely treatment, describing severe symptoms and subsequent health complications, such as asthma. These personal stories underscore the need for increased awareness, testing, and diligent medical response to manage and control the spread of whooping cough in the community.